rood blauwe elepsis logo Belegger.nl

Koffiekamer Terug naar discussie overzicht

AEX – 16/12 – In de ban van Madoff!

660 Posts
Pagina: «« 1 ... 19 20 21 22 23 ... 33 »» | Laatste | Omlaag ↓
  1. [verwijderd] 16 december 2008 20:24
    quote:

    Arthur_Mexico schreef:

    0.75 eraf unaniem
    Wow... rente dus echt nu op 0

    Lijkt leuk nu, maar feitelijk gaat het nog slechter dan gedacht anders hadden ze wel .5 gedaan....
  2. [verwijderd] 16 december 2008 20:24
    quote:

    Arthur_Mexico schreef:

    0.75 eraf unaniem
    Ja en dan, minder dan 0 kan het niet worden. Beurs reageert er iig positief op. Jammer voor mijn SS260.
  3. [verwijderd] 16 december 2008 20:27
    quote:

    M-P schreef:

    [quote=Arthur_Mexico]
    0.75 eraf unaniem
    [/quote]

    Ja en dan, minder dan 0 kan het niet worden. Beurs reageert er iig positief op. Jammer voor mijn SS260.
    Niet getreurd. Altijd eerst even een reactie up, waarna de afstort twee keer zo groot is. Geef het even een half uurtje voordat het inzinkt dat het blijkbaar nodig is om het zover te laten zakken, is geen goed teken.
  4. Ivanrybkin 16 december 2008 20:27
    Dec. 16 (Bloomberg) -- The following is a reformatted version of the full text of the statement released today by the Federal Reserve in Washington:

    The Federal Open Market Committee decided today to establish a target range for the federal funds rate of 0 to 1/4 percent.

    Since the Committee's last meeting, labor market conditions have deteriorated, and the available data indicate that consumer spending, business investment, and industrial production have declined. Financial markets remain quite strained and credit conditions tight. Overall, the outlook for economic activity has weakened further.

    Meanwhile, inflationary pressures have diminished appreciably. In light of the declines in the prices of energy and other commodities and the weaker prospects for economic activity, the Committee expects inflation to moderate further in coming quarters.

    The Federal Reserve will employ all available tools to promote the resumption of sustainable economic growth and to preserve price stability. In particular, the Committee anticipates that weak economic conditions are likely to warrant exceptionally low levels of the federal funds rate for some time.

    The focus of the Committee's policy going forward will be to support the functioning of financial markets and stimulate the economy through open market operations and other measures that sustain the size of the Federal Reserve's balance sheet at a high level. As previously announced, over the next few quarters, the Federal Reserve will purchase large quantities of agency debt and mortgage-backed securities to provide support to the mortgage and housing markets, and it stands ready to expand its purchases of agency debt and mortgage-backed securities and as conditions warrant. The Committee is also evaluating the potential benefits of purchasing longer-term Treasury securities. Early next year, the Federal Reserve will also implement the Term Asset-backed Securities Loan Facility to facilitate the extension of credit to households and small businesses. The Federal Reserve will continue to consider ways of using its balance sheet to further support credit markets and economic activity.

    Voting for the FOMC monetary policy action were: Ben S. Bernanke, Chairman; Christine M. Cumming; Elizabeth A. Duke; Richard W. Fisher; Donald L. Kohn; Randall S. Kroszner; Sandra Pianalto; Charles I. Plosser; Gary H. Stern; and Kevin M. Warsh.

    In a related action, the Board of Governors unanimously approved a 75-basis-point decrease in the discount rate to 1/2 percent. In taking this action, the Board approved the request submitted by the Board of Directors of the Federal Reserve Bank of New York, Cleveland, Richmond, Atlanta, Minneapolis, and San Francisco.

    Last Updated: December 16, 2008 14:21 EST
  5. [verwijderd] 16 december 2008 20:27
    quote:

    M-P schreef:

    [quote=Arthur_Mexico]
    0.75 eraf unaniem
    [/quote]

    Ja en dan, minder dan 0 kan het niet worden. Beurs reageert er iig positief op. Jammer voor mijn SS260.
    Hoe ging het de laatste keer met de renteverlagingen?

    Zonde van mijn 255 maar eerst zien hoe ze sluiten.
660 Posts
Pagina: «« 1 ... 19 20 21 22 23 ... 33 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.001
AB InBev 2 5.485
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.231
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.548
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.654
Aedifica 3 902
Aegon 3.258 322.677
AFC Ajax 538 7.087
Affimed NV 2 6.288
ageas 5.844 109.887
Agfa-Gevaert 14 2.048
Ahold 3.538 74.302
Air France - KLM 1.025 35.007
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.354
Allfunds Group 4 1.468
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 405
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.819
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.836 242.791
AMG 971 133.125
AMS 3 73
Amsterdam Commodities 305 6.686
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 485
Antonov 22.632 153.605
Aperam 92 14.950
Apollo Alternative Assets 1 17
Apple 5 380
Arcadis 252 8.733
Arcelor Mittal 2.033 320.603
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.288
Aroundtown SA 1 219
Arrowhead Research 5 9.721
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.086
ASML 1.766 106.148
ASR Nederland 21 4.452
ATAI Life Sciences 1 7
Atenor Group 1 474
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.610
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.390